Jiangsu Cowin Biotech Co Ltd
688426
Company Profile
Business description
Jiangsu Cowin Biotech Co Ltd is a national high-tech enterprise with independent intellectual property rights based in the field of life sciences. It provides innovative biological products and services to in vitro diagnostic users. The product line mainly includes molecular diagnostic raw materials enzymes, nucleic acid collection and protection agents, nucleic acid extraction kits, molecular diagnostic detection reagents and others.
Contact
No. 1 Yaocheng Avenue
4th Floor, TQB Building
Jiangsu Province
Taizhou225300
CHNT: +86 52386201353
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
770
Stocks News & Analysis
stocks
Jet fuel price spike weighing on Australian airline profits
Fuel volatility can lead to short-term earnings swings but all players bear the cost almost equally.
stocks
US utilities stocks keep rallying as investors bet on power demand growth
Rising electricity demand from data centers supports earnings growth, but Morningstar analysts say the sector looks less attractive after a sharp rally.
stocks
What did Morningstar subscribers buy and sell during March?
How the most traded shares in March stack up against our analysts views.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,181.10 | 29.10 | -0.32% |
| CAC 40 | 8,273.30 | 54.56 | -0.66% |
| DAX 40 | 24,084.28 | 40.06 | 0.17% |
| Dow JONES (US) | 48,381.05 | 154.94 | -0.32% |
| FTSE 100 | 10,572.77 | 36.29 | -0.34% |
| HKSE | 25,947.32 | 75.00 | 0.29% |
| NASDAQ | 23,867.74 | 228.66 | 0.97% |
| Nikkei 225 | 58,134.24 | 256.85 | 0.44% |
| NZX 50 Index | 13,076.58 | 59.32 | 0.46% |
| S&P 500 | 6,996.80 | 29.42 | 0.42% |
| S&P/ASX 200 | 8,978.70 | 32.70 | -0.36% |
| SSE Composite Index | 4,027.21 | 0.58 | 0.01% |